TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 1,241 | 0 | 0 | |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 7.83 | 494 | 3,869 | 2,135 | 2.6 K to 2.1 K (-18.79 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 1,241 | 0 | 2,629 | 1.4 K to 2.6 K (+89.41 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Option Exercise | M | 0.00 | 2,638 | 0 | 0 | |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Sell | S | 7.82 | 962 | 7,523 | 10,678 | 11.6 K to 10.7 K (-8.26 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Buy | M | 0.00 | 2,638 | 0 | 11,640 | 9 K to 11.6 K (+29.30 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 4,091 | 0 | 0 | |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Sell | S | 7.83 | 1,406 | 11,011 | 15,445 | 16.9 K to 15.4 K (-8.34 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Buy | M | 0.00 | 4,091 | 0 | 16,851 | 12.8 K to 16.9 K (+32.06 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 2,376 | 0 | 0 | |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 7.83 | 2,376 | 18,607 | 0 | 2.4 K to 0 (-100.00 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 2,376 | 0 | 2,376 | 0 to 2.4 K |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,446 | 0 | 0 | |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,446 | 0 | 10,595 | 9.1 K to 10.6 K (+15.81 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 2,489 | 0 | 0 | |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 7.82 | 1,176 | 9,197 | 1,676 | 2.9 K to 1.7 K (-41.23 %) |
| Sep 20 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 2,489 | 0 | 2,852 | 363 to 2.9 K (+685.67 %) |
| Sep 11 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 696 | 0 | 698 | |
| Sep 11 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 7.16 | 333 | 2,384 | 363 | 696 to 363 (-47.84 %) |
| Sep 11 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 696 | 0 | 696 | 0 to 696 |